Copyright
©The Author(s) 2016.
World J Gastroenterol. Aug 14, 2016; 22(30): 6817-6828
Published online Aug 14, 2016. doi: 10.3748/wjg.v22.i30.6817
Published online Aug 14, 2016. doi: 10.3748/wjg.v22.i30.6817
Figure 3 Management of duodenal neuroendocrine tumors.
D-NETs: Duodenal neuroendocrine tumors; EUS: Endoscopic ultrasound; CT: Computed tomography; N+: Lymph node metastasis; M+: Distant metastasis; SRS: Somatostatin receptor scintigraphy; PRRT: Peptide receptor radionuclide therapy; SSA: Somatostatin analogues; CHT: Chemotherapy.
- Citation: Sato Y, Hashimoto S, Mizuno KI, Takeuchi M, Terai S. Management of gastric and duodenal neuroendocrine tumors. World J Gastroenterol 2016; 22(30): 6817-6828
- URL: https://www.wjgnet.com/1007-9327/full/v22/i30/6817.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i30.6817